期刊文献+

喹啉类化合物的合成及抗肿瘤活性研究 被引量:3

Synthesis and Antitumor Activity Evaluation of Quinoline Compounds
下载PDF
导出
摘要 以间氟苯胺与乙氧基亚甲基丙二酸二乙酯为原料,经过缩合、高温环合、水解、高温脱羧、氯化,合成7-氟-4-氯-喹啉,7-氟-4-氯-喹啉与不同苯胺反应生成4个喹啉类化合物(J_1~J_4),其结构经过~1H NMR和MS确认.采用MTT法对目标化合物进行体外肿瘤细胞增殖抑制活性评价,结果显示目标化合物具有抑制肿瘤细胞增殖活性. Using m-fluoroanline and ethoxym ethylene oxalic acid ester as starting material,7-fluoro-4-chloro-quinoline was synthesized through cyclization,high temperature cyclization,hydrolysis,high temperature decarboxylation,chlorination. Four quinoline compounds( J1- J4) were synthesized by 7-fluoro-4-chloro-quinoline and different anilines,and their structures were confirmed by -1H NMR and MS. The antiproliferative activity of the compounds against three kinds of cancer cells( SGC7901,HT1080,A549) was evaluated by MTT,and the results showthat the target compounds exhibited inhibitory activity of the three kinds of cancer cells.
作者 刘丹 袁莹 李雪 刘智鑫 LIU Dan;YUAN Ying;LI Xue;LIU Zhi-xin(Shenyang University of Chemical Technology,Shenyang 110142,China)
出处 《沈阳化工大学学报》 CAS 2018年第2期149-152,共4页 Journal of Shenyang University of Chemical Technology
基金 辽宁省教育厅资助项目(L2013171) 辽宁省自然科学基金资助项目(2015020695)
关键词 酪氨酸激酶抑制剂 喹啉类化合物 抗肿瘤活性 tyrosine kinase inhibitors quinoline antitumor activity
  • 相关文献

参考文献3

二级参考文献73

  • 1吴一龙.肺癌分子靶向治疗的个体化[J].循证医学,2004,4(2):67-68. 被引量:9
  • 2曾令国,李勤耕,徐启贵,田睿.抗疟药中间体4,7-二氯喹啉的工艺研究[J].中南药学,2006,4(1):28-29. 被引量:7
  • 3朱红,Tam Yee San Issan,Maria Wong.EGFR突变与非小细胞肺癌酪氨酸激酶抑制剂靶向治疗[J].中国肿瘤生物治疗杂志,2007,14(2):105-109. 被引量:11
  • 4Yarden Y. The EGFR family and its ligands in human cancer, signalling mechanisms and therapeutic opportunities [J].Eur J Cancer, 2001, 37 (Suppl 4) : S3-S8.
  • 5Mimori K, Nagahara H, Sudo T, et al. The epidermal growth factor receptor gene sequence is highly conserved in primarygastric cancers [J]. J Surg Oncol, 2006, 93(1) : 44-46.
  • 6Dhar A, Mehta S, Banerjee S, et al. Epidermal growth factor repeptor: is a novel therapeutic target for pancreatic cancer [J]? Front Biosci, 2005, 10 : 1763-1767.
  • 7Chan JK, Pham H, You X J, et al. Suppression of ovarian cancer cell tumorigenicity and evasion of cisplatin resistance using a truncated epidermal growth factor reeeptor in a rat model [J].Cancer Res, 2005, 65 ( 8 ) : 3243-3248.
  • 8Wu X, Deng Y, Wang G, et al. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells [ J ]. J Surg Res, 2007, 138(1) : 56-63.
  • 9Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic coloreetal cancer [J]. N Engl J Med, 2004, 351 (4) : 337- 345.
  • 10Thienelt CD, Bunn PA Jr, Hanna N, et al. Muhicenter phase I / II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer [ J]. J Clin Oncol, 2005, 23 (34) : 8786-8793.

共引文献47

同被引文献20

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部